PMDA — authorised 23 September 2013
- Marketing authorisation holder: Nobelpharma Co., Ltd.
- Status: approved
🇯🇵 Sclerosol in Japan
PMDA authorised Sclerosol on 23 September 2013
Marketing authorisation
Sclerosol in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in Japan
Frequently asked questions
Is Sclerosol approved in Japan?
Yes. PMDA authorised it on 23 September 2013.
Who is the marketing authorisation holder for Sclerosol in Japan?
Nobelpharma Co., Ltd. holds the Japanese marketing authorisation.